clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2025-103-4-249-262clinmed-1118Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESВыпот в полость перикарда при коронавирусной инфекцииPericardial effusion in coronavirus infectionСукмароваЗ. Н.SukmarovaZ. N.

 Сукмарова Зульфия Наилевна — канд. мед. наук, научный сотрудник, кардиолог 

Москва

 Zulfiya N. Sukmarova — Candidate of Medical Sciences, Researcher, Cardiologist

Moscow

suzulfia@gmail.comСаидоваМ. А.SaidovaM. A.

 Саидова Марина Абдулатиповна — д-р мед. наук, профессор, руководитель отдела функциональной диагностики

Москва

Marina A. Saidova — Doctor of Medical Sciences, Professor, Head of the Department of Functional Diagnostics

Moscow

РыбаковаМ. К.RybakovaM. K.

Рыбакова Марина Константиновна — д-р мед. наук, профессор ультразвуковой диагностики 

Москва

Marina K. Rybakova — Doctor of Medical Sciences, Professor of Ultrasound Diagnostics

Moscow

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationФГБУ «Национальный медицинский исследовательский центр кардиологии имени академика Е.И. Чазова» Минздрава РоссииРоссияE.I. Chazov National Medical Research Center of CardiologyRussian FederationФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияRussian Medical Academy of Continuous Postgraduate Education of the Ministry of HealthRussian Federation2025090820251034249262Copyright © Сукмарова З.Н., Саидова М.А., Рыбакова М.К., 20252025Сукмарова З.Н., Саидова М.А., Рыбакова М.К.Sukmarova Z.N., Saidova M.A., Rybakova M.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/1118

Проблема выпота в полость перикарда касается большого количества нозологий. Сегодня она особенно актуальна в связи с постковидными осложнениями и новыми случаями данной кардиотропной инфекции. Ведение гидроперикарда вызывает множество вопросов: от критериев диагностики, оценки «значимости» до необходимости терапии и выбора ее методов. В данной лекции собраны все ключевые моменты ведения экссудации в полость перикарда, систематизирован подход к диагностике и лечению, подробно освещены наиболее сложные дилеммы, возникающие при ведении такого пациента, а также предложены примеры и собственные наработки в принятии решений, основанные на опыте терапии около тысячи пациентов.

The issue of pericardial effusion concerns a wide range of nosologies. Today, it is particularly relevant in connection with post-COVID complications and new cases of this cardiotropic infection. Managing hydropneumopericardium raises numerous questions: from diagnostic criteria and assessing “significance” to the necessity of therapy and the choice of methods. This lecture compiles all key points regarding the management of effusion in the pericardial cavity, systematizes the approach to diagnosis and treatment, details the most challenging dilemmas that arise when managing such patients, and offers examples and personal insights into decision-making based on the experience of treating nearly a thousand patients.

оценка значимости гидроперикардаведение пациента с выпотом в полость перикардаэкссудативный перикардитосложнение COVID-19assessment of hydropneumopericardium significancemanagement of patients with pericardial effusionexudative pericarditisCOVID-19 complicationsReferencesНасонов Е.Л. Коронавирусная болезнь 2019 (COVID-19): размышления ревматолога. Научно-практическая ревматология. 2020;58(2):123–132. DOI: 10.14412/1995-4484Nasonov E.L. Coronavirus disease 2019 (COVID-19): a rheumatologist’s thoughts. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2020;58(2):123–132. (In Russian)]. DOI: 10.14412/1995-4484-2020-123-132Li P., Shi A., Lu X., Li C., Cai P., Teng C. et al. Incidence and impact of acute pericarditis in hospitalized COVID-19 patients. J. Am. Heart Assoc. 2023;12:e028970. DOI: 10.1161/JAHA.122.028970Li P., Shi A., Lu X., Li C., Cai P., Teng C. et al. Incidence and impact of acute pericarditis in hospitalized COVID-19 patients. J. Am. Heart Assoc. 2023;12:e028970. DOI: 10.1161/JAHA.122.028970Buckley B.J.R., Harrison S.L., Fazio-Eynullayeva E., Underhill P., Lane D.A., Lip G.Y.H. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur. J. Clin. Invest. 2021;51(11):e13679. DOI: 10.1111/eci.13679Buckley B.J.R., Harrison S.L., Fazio-Eynullayeva E., Underhill P., Lane D.A., Lip G.Y.H. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur. J. Clin. Invest. 2021;51(11):e13679. DOI: 10.1111/eci.13679Adler Y., Charron P., Imazio M., Badano L., Barón-Esquivias G., Bogaert J. et al. ESC Scientific Document Group. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2015;36(42):2921–2964. DOI: 10.1093/eurheartj/ehv318Adler Y., Charron P., Imazio M., Badano L., Barón-Esquivias G., Bogaert J. et al. ESC Scientifi c Document Group. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The task force for the diagnosis and management of pericardial diseases of the european society of cardiology (ESC) Endorsed by: the european association for cardio-thoracic surgery (EACTS). Eur. Heart J. 2015;36(42):2921–2964. DOI: 10.1093/eurheartj/ehv318Iskandar R., Liu S., Xiang F., Chen W., Li L., Qin W., Huang F., Chen X. Expression of pericardial fluid T-cells and related inflammatory cytokines in patients with chronic heart failure. Exp. Ther. Med. 2017;13(5):1850–1858. DOI: 10.3892/etm.2017.4202Iskandar R., Liu S., Xiang F., Chen W., Li L., Qin W., Huang F., Chen X. Expression of pericardial fl uid T-cells and related infl ammatory cytokines in patients with chronic heart failure. Exp. Ther. Med. 2017;13(5):1850–1858. DOI: 10.3892/etm.2017.4202Vogiatzidis K., Zarogiannis S.G., Aidonidis I., Solenov E.I., Molyvdas P.A., Gourgoulianis K.I., Hatzoglou C. Physiology of pericardial fluid production and drainage. Front Physiol. 2015 Mar 18;6:62. DOI: 10.3389/fphys.2015.00062Vogiatzidis K., Zarogiannis S.G., Aidonidis I., Solenov E.I., Molyvdas P.A., Gourgoulianis K.I., Hatzoglou C. Physiology of pericardial fl uid production and drainage. Front Physiol. 2015 Mar 18;6:62. DOI: 10.3389/fphys.2015.00062Natanzon A., Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am. J Med. Sci. 2009;338(3):211–6. DOI: 10.1097/MAJ.0b013e3181a3936fNatanzon A., Kronzon I. Pericardial and pleural eff usions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am. J Med. Sci. 2009;338(3):211–6. DOI: 10.1097/MAJ.0b013e3181a3936fСукмарова З.Н., Ибрагимова Ф.М., Ларина О.М., Громов А.И., Насонов Е.Л. Плеврит и перикардит как причина атипичной боли в грудной клетке у пациентов в раннем периоде после COVID-19. Медицинская визуализация. 2022;26(4):11–22. DOI: 10.24835/1607-0763-1232.Sukmarova Z.N., Ibragimova F.M., Larina O.M., Gromov A.I., Nasonov E.L. Pleurisy and pericarditis as a cause of atypical chest pain in patients with in early post-COVID-19 period. Medical Visualization. 2022;26(4): 11–22. (In Russian)]. DOI: 10.24835/1607-0763-1232Lazaros G., Imazio M., Tsioufi s P., Lazarou E., Vlachopoulos C., Tsioufis C. Chronic Pericardial Effusion: Causes and Management. Can. J. Cardiol. 2023;39(8):1121–1131. DOI: 10.1016/j.cjca.2023.02.003Lazaros G., Imazio M., Tsioufi s P., Lazarou E., Vlachopoulos C., Tsioufi s C. Chronic Pericardial Eff usion: Causes and Management. Can. J. Cardiol. 2023;39(8):1121–1131. DOI: 10.1016/j.cjca.2023.02.003Mitiku TY., Heidenreich PA. A small pericardial effusion is a marker of increased mortality. Am. Heart J. 2011 Jan;161(1):152–7. DOI: 10.1016/j.ahj.2010.10.007Mitiku TY., Heidenreich PA. A small pericardial eff usion is a marker of increased mortality. Am. Heart J. 2011 Jan;161(1):152–7. DOI: 10.1016/j.ahj.2010.10.007Насонов Е.Л., Сукмарова З.Н., Попкова Т.В., Белов БС. Проблемы иммунопатологии и перспективы фармакотерапии идиопатического рецидивирующего перикардита: применение ингибитора интерлейкина 1 (анакинра). Научно-практическая ревматология. 2023;61(1):47–61. DOI: 10.47360/1995-4484-2023-47-61Nasonov E.L., Sukmarova Z.N., Popkova T.V., Belov B.S. Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (anakinra). Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2023;61(1):47-61 (In Russian)]. DOI: 10.47360/1995-4484-2023-47-61https://www.vedomosti.ru/society/articles/2023/06/07/979002-rospotrebnadzor-otmetil-tendentsiyu-k-rostu-zabolevaemosti-tuberkulezomhttps://www.vedomosti.ru/society/articles/2023/06/07/979002-rospotrebnadzor-otmetil-tendentsiyu-k-rostu-zabolevaemosti-tuberkulezomSinha A., Yeruva SL., Kumar R., Curry B.H. Early Cardiac Tamponade in a Patient with Postsurgical Hypothyroidism. Case Rep. Cardiol. 2015;2015:310350. DOI: 10.1155/2015/310350.Sinha A., Yeruva SL., Kumar R., Curry B.H. Early Cardiac Tamponade in a Patient with Postsurgical Hypothyroidism. Case Rep. Cardiol. 2015;2015:310350. DOI: 10.1155/2015/310350.Bentata Y., Hamdi F., Chemlal A., Haddiya I., Ismaili N., El Ouafi N. Uremic pericarditis in patients with End Stage Renal Disease: Prevalence, symptoms and outcome in 2017. Am. J. Emerg. Med. 2018 Mar;36(3):464–466. DOI: 10.1016/j.ajem.2017.11.048.Bentata Y., Hamdi F., Chemlal A., Haddiya I., Ismaili N., El Ouafi N. Uremic pericarditis in patients with End Stage Renal Disease: Prevalence, symptoms and outcome in 2017. Am. J. Emerg. Med. 2018 Mar;36(3):464–466. DOI: 10.1016/j.ajem.2017.11.048.Ghantous E., Szekely Y., Lichter Y., Levi E., Taieb P., Banai A. et al. Pericardial involvement in patients hospitalized with COVID-19: prevalence, associates, and clinical implications. J. Am. Heart Assoc. 2022;11(7):e024363. DOI: 10.1161/JAHA.121.024363Ghantous E., Szekely Y., Lichter Y., Levi E., Taieb P., Banai A. et al. Pericardial involvement in patients hospitalized with COVID-19: prevalence, associates, and clinical implications. J. Am. Heart Assoc. 2022;11(7):e024363. DOI: 10.1161/JAHA.121.024363Ramadan MS., Bertolino L., Zampino R., Durante-Mangoni E; Monaldi Hospital Cardiovascular Infection Study Group. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin. Microbiol. Infect. 2021;27(9):1250–1261. DOI: 10.1016/j.cmi.2021.06.015Ramadan MS., Bertolino L., Zampino R., Durante-Mangoni E; Monaldi Hospital Cardiovascular Infection Study Group. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin. Microbiol. Infect. 2021;27(9):1250–1261. DOI: 10.1016/j.cmi.2021.06.015Сукмарова З.Н., Потапов Е.В., Саидова М.А., Овчинников Ю.В., Громов А.И. Изменения перикарда, ассоциированные с инфекцией SARS-CoV-2. Проспективное наблюдение в ковидном центре. REJR 2022; 12(4):30-47. DOI: 10.21569/2222-7415-2022-12-4-30-47.Sukmarova Z.N., Potapov E.V., Saidova M.A., Ovchinnikov Yu.V., Gromov A.I. Pericardial involvement associated with SARS-COV-2 infection. Prospective observation in the COVID- ward. REJR. 2022; 12(4):30–47. (In Russian)]. DOI: 10.21569/2222-7415-2022-12-4-30-47Dini F.L., Baldini U., Bytyçi I., Pugliese N.R., Bajraktari G., Henein M.Y. Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome. Int. J. Cardiol. 2023;374:129–134. DOI: 10.1016/j.ijcard.2022.12.019Dini F.L., Baldini U., Bytyçi I., Pugliese N.R., Bajraktari G., Henein M.Y. Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome. Int. J. Cardiol. 2023;374:129–134. DOI: 10.1016/j.ijcard.2022.12.019Hanley B., Naresh K.N., Roufosse C., Nicholson A.G., Weir J., Cooke G.S. et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245–e253. DOI: 10.1016/S2666-5247(20)30115-4.Hanley B., Naresh K.N., Roufosse C., Nicholson A.G., Weir J., Cooke G.S. et al. Histopathological fi ndings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245–e253. DOI: 10.1016/S2666-5247(20)30115-4.Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. DOI: 10.1001/jamacardio.2020.3557Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoff mann J. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. DOI: 10.1001/jamacardio.2020.3557Сукмарова З.Н., Симоненко В.Б., Ибрагимова Ф.М., Демьяненко А.В. Экссудативный перикардит как новый специфичный симптом SARS-CoV-2. Клиническая медицина. 2021;99(3):192–197. Doi:10.30629/0023-2149-2021-99-3-192-197.Sukmarova Z.N., Simonenko V.B., Ibragimova F.M., Demyanenko A.V. Pericardial eff usion as a new specifi c symptom of SARS-CoV-2. Klinicheskaya meditsina. 2021;99(3):192–197. (In Russian)]. DOI: 10.30629/0023-2149-2021-99-3-192-197Luk A., Clarke B., Dahdah N., Ducharme A. et al. Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Can. J. Cardiol 2021;37:1629–34.Luk A., Clarke B., Dahdah N., Ducharme A. et al. Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Can. J. Cardiol 2021;37:1629–34.Сукмарова З.Н.., Овчинников Ю.В.., Гудима Г.О.., Ибрагимова Ф.М.., Афонина О.В.., Мачкалян К.Э. Усиление эхо-сигнала от перикарда у реципиентов вакцин против SARS-CoV-2. Инфекционные болезни. DOI: 10.20953/1729-9225-2021-4-43-50Sukmarova Z.N., Ovchinnikov Yu.V., Gudima G.O. et al. Hyperechogenic signal from the pericardium after vaccination against SARS-CoV-2. Infectious diseases, 2021;19(4):43–50. (In Russian)]. DOI: 10.20953/1729-9225-2021-4-43-50Kermani-Alghoraishi M., Pouramini A., Kafi F., Khosravi A. Coronavirus Disease 2019 (COVID-19) and Severe Pericardial Effusion: From Pathogenesis to Management: A Case Report Based Systematic Review. Curr. Probl. Cardiol. 2022;47(2):100933. DOI: 10.1016/j.cpcardiol.2021.100933Kermani-Alghoraishi M., Pouramini A., Kafi F., Khosravi A. Coronavirus Disease 2019 (COVID-19) and Severe Pericardial Eff usion: From Pathogenesis to Management: A Case Report Based Systematic Review. Curr. Probl. Cardiol. 2022;47(2):100933. DOI: 10.1016/j.cpcardiol.2021.100933Imazio M., Adler Y. Management of pericardial effusion. Eur. Heart J. 2013;34(16):1186-97. DOI: 10.1093/eurheartj/ehs372Imazio M., Adler Y. Management of pericardial eff usion. Eur. Heart J. 2013;34(16):1186-97. DOI: 10.1093/eurheartj/ehs372Рыбакова М.К., Митьков В.В. Эхокардиография в таблицах и схемах. Настольный справочник. Изд.3-е. ВИДАР. 2016. ISBN 978-5-88429-231-4Rybakova M.K., Mitkov V.V. Echocardiography in tables and diagrams. Desktop reference. 3rd ed. VIDAR. 2016. (In Russian). ISBN 978-5-88429-231-4Cosyns B., Plein S., Nihoyanopoulos P., Smiseth O., Achenbach S., Andrade M.J., Pepi M., Ristic A., Imazio M., Paelinck B., Lancellotti P; European Association of Cardiovascular Imaging (EACVI); European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseases. European Association of Car diovascular Imaging (EACVI) position paper: Multimodality imaging in pericardial disease. Eur. Heart J. Cardiovasc. Imaging. 2015;16(1):12–31. DOI: 10.1093/ehjci/jeu128Cosyns B., Plein S., Nihoyanopoulos P., Smiseth O., Achenbach S., Andrade M.J., Pepi M., Ristic A., Imazio M., Paelinck B., Lancel lotti P; European Association of Cardiovascular Imaging (EACVI); European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseases. European Association of Car diovascular Imaging (EACVI) position paper: Multimodality im aging in pericardial disease. Eur. Heart J. Cardiovasc. Imaging. 2015;16(1):12–31. DOI: 10.1093/ehjci/jeu128Chetrit M., Xu B., Kwon D.H., Ramchand J., Rodriguez R.E., Tan C.D., Jellis C.L., Johnston D.R., Renapurkar RD., Cremer P.C., Klein A.L. Imaging-Guided Therapies for Pericardial Diseases. JACC Cardiovasc Imaging. 2020;13(6):1422–1437. DOI: 10.1016/j.jcmg.2019.08.027Chetrit M., Xu B., Kwon D.H., Ramchand J., Rodriguez R.E., Tan C.D., Jellis C.L., Johnston D.R., Renapurkar RD., Cremer P.C., Klein A.L. Imaging-Guided Therapies for Pericardial Diseases. JACC Cardiovasc Imaging. 2020;13(6):1422–1437. DOI: 10.1016/j.jcmg.2019.08.027Hyeon C.W., Yi H.K., Kim E.K. et al. The role of 18F-fluorodeoxy glucosee positron emission tomography/computed tomography in the differential diagnosis of pericardial disease. Sci. Rep. 2020;10:21524.Hyeon C.W., Yi H.K., Kim E.K. et al. The role of 18F-fl uorodeoxy glucosee positron emission tomography/computed tomography in the diff erential diagnosis of pericardial disease. Sci. Rep. 2020;10:21524.Burazor I., Aviel-Ronen S., Imazio M., Goitein O., Perelman M., Shelestovich N., Radovanovic N., Kanjuh V., Barshack I., Adler Y. Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment. BMC Cancer. 2018;18(1):202. DOI: 10.1186/s12885-018-4070-xBurazor I., Aviel-Ronen S., Imazio M., Goitein O., Perelman M., Shelestovich N., Radovanovic N., Kanjuh V., Barshack I., Adler Y. Metastatic cardiac tumors: from clinical presentation through di agnosis to treatment. BMC Cancer. 2018;18(1):202. DOI: 10.1186/s12885-018-4070-xBuoro S., Tombetti E., Ceriotti F., Simon C., Cugola D., Seghez zi M., Innocente F., Maestroni S., Del Carmen Baigorria Vaca M., Moioli V., Previtali G., Manenti B., Adler Y., Imazio M., Bruca to A. What is the normal composition of pericardial fluid? Heart. 2021;107(19):1584–1590. DOI: 10.1136/heartjnl-2020-317966Buoro S., Tombetti E., Ceriotti F., Simon C., Cugola D., Seghez zi M., Innocente F., Maestroni S., Del Carmen Baigorria Vaca M., Moioli V., Previtali G., Manenti B., Adler Y., Imazio M., Bruca to A. What is the normal composition of pericardial fl uid? Heart. 2021;107(19):1584–1590. DOI: 10.1136/heartjnl-2020-317966Humbert M., Kovacs G., Hoeper MM. et al. ESC/ERS Scientific Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2022;43:3618–731Humbert M., Kovacs G., Hoeper MM. et al. ESC/ERS Scientifi c Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2022;43:3618–731Afonso L, Kottam A, Reddy V, Penumetcha A. Echocardiography in Infective Endocarditis: State of the Art. Curr Cardiol Rep. 2017;19(12):127. doi: 10.1007/s11886-017-0928-9.Afonso L, Kottam A, Reddy V, Penumetcha A. Echocardiography in Infective Endocarditis: State of the Art. Curr Cardiol Rep. 2017;19(12):127. doi: 10.1007/s11886-017-0928-9.Сукмарова З.Н., Паршин В.В., Шишиморов А.А., Громов А.И. Полисерозит как негативный прогностический фактор COVID-19. Наблюдения ГКБ №52 в начале и в конце пандемии. Медицинская визуализация. doi:10.24835/1607-0763-1496Sukmarova Z.N., Shishimorov A.A., Parshin V.V., Gromov A.I. Patients monitoring in the City Clinical Hospital No. 52 at the beginning and end of the pandemic. Medical Visualization. (In Russ.). doi:10.24835/1607-0763-1496Søgaard K.K., Farkas D.K., Ehrenstein V., Bhaskaran K., Bøtker H.E., Sørensen H.T. Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation. 2017;136:996–1006Søgaard K.K., Farkas D.K., Ehrenstein V., Bhaskaran K., Bøtker H.E., Sørensen H.T. Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation. 2017;136:996–1006Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011;97(22):1882–92. DOI: 10.1136/heartjnl-2011-300054Imazio M. Pericardial involvement in systemic infl ammatory diseases. Heart. 2011;97(22):1882–92. DOI: 10.1136/heartjnl-2011-300054Сукмарова З.Н., Саидова М.А., Овчинников Ю.В. Экссудативный перикардит в патогенезе нарушений ритма сердца при COVID-19: серия клинических случаев. Кардиоваскулярная терапия и профилактика. 2022;21(2):3021. DOI: 10.15829/1728-8800-2022-3021.Sukmarova Z.N., Saidova M.A., Ovchinnicov Yu.V. Eff usive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series. Cardiovascular Therapy and Prevention. 2022;21(2):3021. (In Russian)]. DOI: 10.15829/1728-8800-2022-3021Сукмарова З.Н., Зоткин Е.Г. Терапия нарушений ритма сердца, ассоциированных с инфекцией SARS-CoV-2, противовоспалительными средствами. Клиническая медицина. 2023;101(12):665-674.Sukmarova Z.N., Zotkin E.G. Therapy of cardiac arrhythmias associated with SARS-CoV-2 infection with anti-infl ammatory drugs. Clinical medicine. 2023;101(12):665–674. (In Russian). DOI: 10.30629/0023-2149-2023-101-12-665-674Рыбакова М.К., Алехин М.Н., Митьков В.В.. Практическое руководство по ультразвуковой диагностике. Эхокардиография. ВИДАР. Москва. 2008Rybakova M.K. Rybakova, Alekhine M.N. Alekhine, Mitkov V.V. Mitkov. A practical guide to ultrasound diagnostics. Echocardiography. VIDAR. Moscow. 2008. (In Russian)].Imazio M., Gaido L., Battaglia A., Gaita F. Contemporary management of pericardial effusion: practical aspects for clinical practice. Postgrad. Med. 2017;129(2):178–186. DOI: 10.1080/00325481.2017.1285676Imazio M., Gaido L., Battaglia A., Gaita F. Contemporary management of pericardial eff usion: practical aspects for clinical practice. Postgrad. Med. 2017;129(2):178–186. DOI: 10.1080/00325481.2017.1285676Ristić A.D., Imazio M., Adler Y., Anastasakis A., Badano L.P., Brucato A., Caforio A.L., Dubourg O., Elliott P., Gimeno J., Helio T., Klingel K., Linhart A., Maisch B., Mayosi B., Mogensen J., Pinto Y., Seggewiss H., Seferović P.M., Tavazzi L., Tomkowski W., Charron P. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2014;35(34):2279–84. DOI: 10.1093/eurheartj/ehu217Ristić A.D., Imazio M., Adler Y., Anastasakis A., Badano L.P., Brucato A., Caforio A.L., Dubourg O., Elliott P., Gimeno J., Helio T., Klingel K., Linhart A., Maisch B., Mayosi B., Mogensen J., Pinto Y., Seggewiss H., Seferović P.M., Tavazzi L., Tomkowski W., Charron P. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2014;35(34):2279–84. DOI: 10.1093/eurheartj/ehu217Sagristà-Sauleda J., Angel J., Permanyer-Miralda G, Soler Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N. Engl. J. Med. 1999;341(27):2054–9. DOI: 10.1056/NEJM199912303412704Sagristà-Sauleda J., Angel J., Permanyer-Miralda G, Soler Soler J. Long-term follow-up of idiopathic chronic pericardial eff usion. N. Engl. J. Med. 1999;341(27):2054–9. DOI: 10.1056/NEJM199912303412704Imazio M., Lazaros G., Valenti A., De Carlini C.C., Maggiolini S., Pivetta E., Giustetto C., Tousoulis D., Adler Y., Rinaldi M., Brucato A. Outcomes of idiopathic chronic large pericardial effusion. Heart. 2019;105(6):477–481. DOI: 10.1136/heartjnl-2018-313532Imazio M., Lazaros G., Valenti A., De Carlini C.C., Maggiolini S., Pivetta E., Giustetto C., Tousoulis D., Adler Y., Rinaldi M., Brucato A. Outcomes of idiopathic chronic large pericardial eff usion. Heart. 2019;105(6):477–481. DOI: 10.1136/heartjnl-2018-313532Mitiku T.Y., Heidenreich P.A. A small pericardial effusion is a marker of increased mortality. Am. Heart J. 2011;161(1):152–7. DOI: 10.1016/j.ahj.2010.10.007Mitiku T.Y., Heidenreich P.A. A small pericardial eff usion is a marker of increased mortality. Am. Heart J. 2011;161(1):152–7. DOI: 10.1016/j.ahj.2010.10.007Ghosh A.K., Crake T., Manisty C., Westwood M. Pericardial Disease in Cancer Patients. Curr. Treat. Options Cardiovasc. Med. 2018;20(7):60. DOI: 10.1007/s11936-018-0654-7Ghosh A.K., Crake T., Manisty C., Westwood M. Pericardial Disease in Cancer Patients. Curr. Treat. Options Cardiovasc. Med. 2018;20(7):60. DOI: 10.1007/s11936-018-0654-7Maisch B., Rupp H., Ristic A., Pankuweit S. Pericardioscopy and epi- and pericardial biopsy — a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail Rev. 2013;18(3):317–28. DOI: 10.1007/s10741-013-9382-yMaisch B., Rupp H., Ristic A., Pankuweit S. Pericardioscopy and epi- and pericardial biopsy — a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail Rev. 2013;18(3):317–28. DOI: 10.1007/s10741-013-9382-yFröhlich G.M., Keller P., Schmid F., Wolfrum M., Osranek M., Falk C., Noll G., Enseleit F., Reinthaler M., Meier P., Lüscher T.F., Ruschitzka F., Tanner F.C. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. Eur. Heart J. 2013;34(19):1414–23. DOI: 10.1093/eurheartj/eht006Fröhlich G.M., Keller P., Schmid F., Wolfrum M., Osranek M., Falk C., Noll G., Enseleit F., Reinthaler M., Meier P., Lüscher T.F., Ruschitzka F., Tanner F.C. Haemodynamically irrelevant pericardial eff usion is associated with increased mortality in patients with chronic heart failure. Eur. Heart J. 2013;34(19):1414–23. DOI: 10.1093/eurheartj/eht006Chen Y.-F., Hsieh M.-R., Chang C.-T., Tsai P.-H., Fang Y.-F. Exploring the Risk Factors for Poor Survival in Lupus Pericarditis Patients: A Retrospective Cohort Study. Journal of Clinical Medicine. 2022;11(18):5473. DOI: 10.3390/jcm11185473Chen Y.-F., Hsieh M.-R., Chang C.-T., Tsai P.-H., Fang Y.-F. Exploring the Risk Factors for Poor Survival in Lupus Pericarditis Patients: A Retrospective Cohort Study. Journal of Clinical Medicine. 2022;11(18):5473. DOI: 10.3390/jcm11185473De Filippo O., Gatti P., Rettegno S., Iannaccone M., D’Ascenzo F., Lazaros G., Brucato A., Tousoulis D., Adler Y., Imazio M. Is pericardial effusion a negative prognostic marker? Meta-analysis of outcomes of pericardial effusion. J. Cardiovasc. Medю. (Hagerstown). 2019;20(1):39–45. DOI: 10.2459/JCM.0000000000000720De Filippo O., Gatti P., Rettegno S., Iannaccone M., D’Ascenzo F., Lazaros G., Brucato A., Tousoulis D., Adler Y., Imazio M. Is pericardial eff usion a negative prognostic marker? Meta-analysis of outcomes of pericardial eff usion. J. Cardiovasc. Medю. (Hagerstown). 2019;20(1):39–45. DOI: 10.2459/JCM.0000000000000720Bucher A.M., Henzel K., Meyer H.J., Ehrengut C., Müller L., Schramm D., Akinina A., Drechsel M., Kloeckner R., Isfort P., Sähn M.J., Fink M., More D., Melekh B., Meinel F.G., Dreger F., May M., Siegler L., Münzfeld H., Ruppel R., Penzkofer T., Kim M.S., Balzer M., Borggrefe J., Surov A. Pericardial Effusion Predicts Clinical Outcomes in Patients with COVID-19: A Nationwide Multicenter Study. Acad. Radiol. 2024;31(5):1784–1791. DOI: 10.1016/j.acra.2023.12.003Bucher A.M., Henzel K., Meyer H.J., Ehrengut C., Müller L., Schramm D., Akinina A., Drechsel M., Kloeckner R., Isfort P., Sähn M.J., Fink M., More D., Melekh B., Meinel F.G., Dreger F., May M., Siegler L., Münzfeld H., Ruppel R., Penzkofer T., Kim M.S., Balzer M., Borggrefe J., Surov A. Pericardial Eff usion Predicts Clinical Outcomes in Patients with COVID-19: A Nationwide Multicenter Study. Acad. Radiol. 2024;31(5):1784–1791. DOI: 10.1016/j.acra.2023.12.003Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., Seward J.B. Outcomes of clinically significant idiopathic pericardial effusion requiring intervention. Am. J. Cardiol. 2003;91(6):704–7. DOI: 10.1016/s0002-9149(02)03408-2Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., Seward J.B. Outcomes of clinically signifi cant idiopathic pericardial eff usion requiring intervention. Am. J. Cardiol. 2003;91(6):704–7. DOI: 10.1016/s0002-9149(02)03408-2Сукмарова З.Н., Симоненко В.Б., Насонов Е.Л. Лечение больных перикардитом противовоспалительными средства ми. Клиническая медицина. 2022;100(11–12):509–519. DOI: 10.30629/0023-2149-2022-100-11-12-509-519.Sukmarova Z.N., Simonenko V.B., Nasonov E.L. Treatment of patients with pericarditis with anti-inflammatory drugs. Clinical Medicine (Russian Journal). 2022;100(11–12):509–519. (In Russian)]. DOI: 10.30629/0023-2149-2022-100-11-12-509-519Kim S.R., Kim E.K., Cho J., Chang S.A., Park S.J., Lee S.C., Park S.W. Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion. J. Am. Coll. Cardiol. 2020;76(13):1551–1561. DOI: 10.1016/j.jacc.2020.08.003Kim S.R., Kim E.K., Cho J., Chang S.A., Park S.J., Lee S.C., Park S.W. Eff ect of Anti-Infl ammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Eff usion. J. Am. Coll. Cardiol. 2020;76(13):1551–1561. DOI: 10.1016/j.jacc.2020.08.003Lazaros G., Antonopoulos AS., Lazarou E., Vlachopoulos C., Foukarakis E., Androulakis A., Manginas A., Theodoros K., Karavidas A., Tousoulis D. Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions. Am. J. Cardiol. 2020;126:89–93. DOI: 10.1016/j.amjcard.2020.03.035Lazaros G., Antonopoulos AS., Lazarou E., Vlachopoulos C., Foukarakis E., Androulakis A., Manginas A., Theodoros K., Karavidas A., Tousoulis D. Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignifi cant, C-Reactive Protein Negative, Idiopathic Pericardial Eff usions. Am. J. Cardiol. 2020;126:89–93. DOI: 10.1016/j.amjcard.2020.03.035Virk S.A., Chandrakumar D., Villanueva C., Wolfenden H., Liou K., Cao C. Systematic review of percutaneous interventions for malignant pericardial effusion. Heart. 2015;101:1619–1626. DOI: 10.1136/heartjnl-2015-307907Virk S.A., Chandrakumar D., Villanueva C., Wolfenden H., Liou K., Cao C. Systematic review of percutaneous interventions for malignant pericardial eff usion. Heart. 2015;101:1619–1626. DOI: 10.1136/heartjnl-2015-307907Kunitoh H., Tamura T., Shibata T., et al. A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br. J. Cancer. 2009;100:464–469. DOI: 10.1038/sj.bjc.6604866Kunitoh H., Tamura T., Shibata T., et al. A randomised trial of intrapericardial bleomycin for malignant pericardial eff usion with lung cancer (JCOG9811). Br. J. Cancer. 2009;100:464–469. DOI: 10.1038/sj.bjc.6604866Saraç İ., Aydın S.Ş., Özmen M., Doru H.İ., Tonkaz G., Çırçır M.N., Akpınar F., Zengin O., Delice O., Aydınyılmaz F. Prevalence, Risk Factors, Prognosis, and Management of Pericardial Effusion in COVID-19. J. Cardiovasc. Dev. Dis. 2023;10(9):ан368. DOI: 10.3390/jcdd10090368Saraç İ., Aydın S.Ş., Özmen M., Doru H.İ., Tonkaz G., Çırçır M.N., Akpınar F., Zengin O., Delice O., Aydınyılmaz F. Prevalence, Risk Factors, Prognosis, and Management of Pericardial Eff usion in COVID-19. J. Cardiovasc. Dev. Dis. 2023;10(9):ан368. DOI: 10.3390/jcdd10090368

The authors declare that there are no conflicts of interest present.